Human Papillomavirus Infection and Knowledge and Attitudes About HPV Vaccines Among Men Who Have Sex With Men (MSM)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2011 by Chinese Academy of Medical Sciences.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Chinese Academy of Medical Sciences
ClinicalTrials.gov Identifier:
NCT01300689
First received: February 22, 2011
Last updated: NA
Last verified: February 2011
History: No changes posted
  Purpose

This is a observational study aims to assess anal and genital human papillomavirus (HPV) infection status among men who have sex with men (MSM) in China, and their knowledge and attitude about HPV vaccine.


Condition
HPV Infection
HIV Infection
Syphilis

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional

Resource links provided by NLM:


Further study details as provided by Chinese Academy of Medical Sciences:

Estimated Enrollment: 3000
Study Start Date: July 2011
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

A total of 3,000 eligible men who have sex with men (MSM) with 300 from each city will be enrolled from ten cities (BeiJing, ShangHai, TianJin, ChongQing, GuangZhou, ZhengZhou, Harbin, ShenYang, ChengDu, and KunMing) by the local CDCs and non-government MSM organizations

Criteria

Inclusion Criteria:

  • ≥ 18 years old;
  • Ever had homosexual behaviors in the past 12 months;
  • Willing to take tests for HIV/HPV infection;
  • Physically able and willing to provide written informed consent.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01300689

Contacts
Contact: XiangWei Li, MD 86-10-67855012 xiangweili@ipbcams.ac.cn

Locations
China, Beijing
Institute of Pathogen Biology (IPB) Not yet recruiting
Beijing, Beijing, China, 100730
Contact: Yu Yang, MD       wolfson@ipbcams.ac.cn   
Principal Investigator: Lei Gao, Ph. D.         
Sponsors and Collaborators
Chinese Academy of Medical Sciences
Investigators
Principal Investigator: Lei Gao, Ph.D. Institute of Pathogen Biology (IPB), CAMS&PUMC
  More Information

Publications:
Responsible Party: Lei Gao, Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College
ClinicalTrials.gov Identifier: NCT01300689     History of Changes
Other Study ID Numbers: HPV and MSM in China
Study First Received: February 22, 2011
Last Updated: February 22, 2011
Health Authority: China: Ministry of Health

Keywords provided by Chinese Academy of Medical Sciences:
HPV
MSM
Vaccine
China

Additional relevant MeSH terms:
Acquired Immunodeficiency Syndrome
Communicable Diseases
HIV Infections
Infection
Papillomavirus Infections
DNA Virus Infections
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Tumor Virus Infections
Virus Diseases

ClinicalTrials.gov processed this record on October 30, 2014